Today: 25 January 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

ST Engineering (SGX: S63) Stock: 9M 2025 Results, Dividend Upgrade and Space Contract Fuel Long‑Term Growth Story

ST Engineering (SGX: S63) Stock: 9M 2025 Results, Dividend Upgrade and Space Contract Fuel Long‑Term Growth Story

Singapore Technologies Engineering Ltd – better known as ST Engineering – has quietly turned into one of the most interesting stocks on the Singapore Exchange. Its businesses now stretch from aircraft maintenance to metro systems, cyber‑security, quantum‑safe networking and, as of late November, building a high‑end radar satellite for the UAE. As of 2 December 2025, ST Engineering’s share price…
2 December 2025
···
Yangzijiang Shipbuilding (SGX: BS6) Stock Today: Price, Order Book and Analyst Forecasts on 2 December 2025

Yangzijiang Shipbuilding (SGX: BS6) Stock Today: Price, Order Book and Analyst Forecasts on 2 December 2025

Yangzijiang Shipbuilding (Holdings) Ltd (“Yangzijiang” or “YZJ”) has gone from panic to fresh optimism in 2025. After a sharp sell-off triggered by proposed U.S. port fees on Chinese-built ships earlier this year, the Singapore‑listed stock has rebounded on the back of a huge “green” order book, strong profitability and increasingly bullish analyst targets. Nextinsight This article summarises the latest share…
2 December 2025
···
Singapore Exchange (SGX:S68) Stock Outlook as of 2 December 2025: Price, Dividend and New Growth Catalysts

Singapore Exchange (SGX:S68) Stock Outlook as of 2 December 2025: Price, Dividend and New Growth Catalysts

Updated: 2 December 2025 Singapore Exchange Limited (SGX:S68) has quietly turned into one of the stronger performers on the Singapore market in 2025. The bourse operator has delivered double‑digit revenue growth, steady dividend increases and, more recently, two headline catalysts: a landmark dual‑listing tie‑up with Nasdaq and the launch of institutional‑grade crypto perpetual futures. sgxgroup.com This article pulls together the…
2 December 2025
····
United Overseas Bank (SGX: U11) Stock: Q3 2025 Earnings Shock, 6% Yield and 2026 Outlook – Is It Now a Value Play?

United Overseas Bank (SGX: U11) Stock: Q3 2025 Earnings Shock, 6% Yield and 2026 Outlook – Is It Now a Value Play?

United Overseas Bank Limited (UOB, SGX: U11) is back in the spotlight after a brutal third-quarter earnings surprise, fresh covered bond issuance and a chunky dividend stream that now translates into a yield of around 5–6% at current prices. As of 2 December 2025, UOB shares trade around S$34.33, roughly 12% below their 52‑week high of S$39.20 and above the…
2 December 2025
···
Singtel (SGX: Z74) Stock Outlook as of 2 December 2025: 50% Rally, UBS Downgrade, AI Data Centres and Dividend Growth

Singtel (SGX: Z74) Stock Outlook as of 2 December 2025: 50% Rally, UBS Downgrade, AI Data Centres and Dividend Growth

Singapore Telecommunications Limited (Singtel, SGX: Z74) has quietly turned into one of 2025’s star performers on the Singapore market. The share price has surged about 51% over the past 12 months to around S$4.68 as of midday on 2 December 2025, near its 52‑week high of S$4.92. StockAnalysis That kind of run is exactly what attracts both fans and skeptics.…
2 December 2025
···
OCBC Stock (SGX: O39) December 2025 Outlook: Share Price Near Highs, Fat Dividends and a New WeChat Pay Catalyst

OCBC Stock (SGX: O39) December 2025 Outlook: Share Price Near Highs, Fat Dividends and a New WeChat Pay Catalyst

OCBC share price today: near record highs after a strong November Oversea-Chinese Banking Corporation Limited (“OCBC”, SGX: O39) is trading close to all‑time highs as December 2025 begins. By mid‑morning on 2 December 2025, OCBC shares were changing hands at around S$18.7 on the Singapore Exchange, with BusinessToday reporting S$18.74 at 9:16am and Beansprout showing S$18.69 shortly after. BusinessToday On…
2 December 2025
····
DBS Group Holdings Stock (SGX: D05): Price, Dividend, Forecast and Latest News as of 2 December 2025

DBS Group Holdings Stock (SGX: D05): Price, Dividend, Forecast and Latest News as of 2 December 2025

DBS Group Holdings Ltd (SGX: D05) has quietly turned into one of Asia’s most watched bank stocks: near-record share price, a hefty dividend that’s still growing, and a long list of big‑ticket digital and cross‑border initiatives. As of 2 December 2025, the conversation has shifted from “Is DBS cheap?” to “How much premium is too much for a best‑in‑class bank?”…
2 December 2025
····
Genting Singapore Limited (SGX:G13): Share Price, New York Casino Catalyst and Q4 2025 Outlook as of 2 December 2025

Genting Singapore Limited (SGX:G13): Share Price, New York Casino Catalyst and Q4 2025 Outlook as of 2 December 2025

Singapore – 2 December 2025 Genting Singapore Limited, owner of Resorts World Sentosa (RWS), is back in the spotlight as its share price trades around S$0.75–0.76 and its parent group secures a coveted full casino licence in New York City — a development that could indirectly reshape expectations for Genting Singapore’s dividends and long‑term growth story. Beansprout Below is a…
2 December 2025
··
BlueScope Steel (ASX:BSL): Share Price, Buy‑Back, Gas Battle and 2026 Outlook as at 2 December 2025

BlueScope Steel (ASX:BSL): Share Price, Buy‑Back, Gas Battle and 2026 Outlook as at 2 December 2025

BlueScope Steel Limited (ASX:BSL) is ending 2025 as one of the more complicated stories on the ASX 200: a cyclical steel producer with depressed earnings, a huge blast‑furnace reline underway, a very aggressive share buy‑back, an outspoken campaign on gas prices, a tragic fatality at its flagship Port Kembla plant and a new CEO about to step in. For investors…
2 December 2025
···
Wesfarmers (ASX:WES) Stock on 2 December 2025: Dividend Windfall, OpenAI Deal and 2026 Share Price Outlook

Wesfarmers (ASX:WES) Stock on 2 December 2025: Dividend Windfall, OpenAI Deal and 2026 Share Price Outlook

Wesfarmers Limited (ASX:WES) heads into the first week of December 2025 as one of the most closely watched blue‑chip stocks on the ASX. A large capital management payout lands this week, fresh broker research has landed, and the conglomerate has just announced a partnership with OpenAI that underlines how seriously it is taking AI‑driven retail and data. TS2 Tech Below…
2 December 2025
···
WiseTech Global (ASX:WTC) Share Price on 2 December 2025: Governance Shock, New Pricing Model and 2026 Outlook

WiseTech Global (ASX:WTC) Share Price on 2 December 2025: Governance Shock, New Pricing Model and 2026 Outlook

Updated: 2 December 2025 WiseTech Global Ltd (ASX:WTC) has just closed another volatile trading day with its share price sitting around A$70.25, down roughly 1–2% on the session and still more than 40% below its 2025 peak above A$130. StockAnalysis Yet under the surface of that bruised share price sits a logistics software giant posting double‑digit revenue growth, rolling out…
2 December 2025
·
South32 (ASX: S32) Stock on 2 December 2025: Cerro Matoso Exit, New Director and the Energy-Transition Pivot

South32 (ASX: S32) Stock on 2 December 2025: Cerro Matoso Exit, New Director and the Energy-Transition Pivot

South32 Limited (ASX: S32, LSE/JSE: S32, ADR: SOUHY) begins December 2025 in the middle of a strategic reshuffle: it has completed the sale of its Colombian nickel business, is bedding down a major copper and zinc growth pipeline, and has just added a heavyweight ex‑BHP risk and sustainability specialist to its board. AFR Company Announcements For investors scanning the South32…
2 December 2025
···
1 … 654 655 656 657 658 … 711

Stock Market Today

  • Is Stryker (SYK) Overvalued After Recent Share Price Drop?
    January 24, 2026, 7:19 PM EST. Stryker's shares slipped 9.1% over the past year but show strong gains of 43.8% over three years and 69.1% over five years. The medical technology firm's stock closed at $355.04, prompting debate on whether it prices in too much optimism. A Discounted Cash Flow (DCF) analysis estimates intrinsic value at $298.65 per share, suggesting the stock trades at an 18.9% premium and is overvalued on this metric. Other valuation checks yield mixed signals, with Stryker scoring 1 out of 6 indicating undervaluation in only one measure. Investors continue to balance its long-term healthcare role against current pricing, contributing to short-term weakness amid solid multi-year returns. The mixed valuation results highlight ongoing uncertainty about the stock's fair value amid evolving growth prospects and risk assessments.
Go toTop